Inguinal hernia, bilateral

HERING_BILATERAL

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

2 out of 7 registries used, show all original rules.

4216

4. Check minimum number of events

None

4216

5. Include endpoints

None

4216

6. Filter based on genotype QC (FinnGen only)

4216

Control definitions (FinnGen only)

Control exclude
K11_HERNIA

Extra metadata

First used in FinnGen datafreeze
DF3

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 32945 3598 29171
Only index persons 30071 3207 26864
Unadjusted period prevalence (%)
Whole population 0.73 0.10 0.82
Only index persons 0.93 0.12 1.03
Median age at first event (years)
Whole population 60.00 58.80 60.10
Only index persons 59.60 58.64 59.71

-FinnGen-

Key figures

All Female Male
Number of individuals 4216 442 3774
Unadjusted period prevalence (%) 1.51 0.15 1.66
Median age at first event (years) 62.09 55.80 62.82

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3758
Matched controls
37575
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
1087.4
323.0
1662
27
JAB12
NOMESCO Finland
Laparoscopic repair of inguinal hernia, TEP
+∞
323.0
443
*
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
9663.9
323.0
3300
25
JAB11
NOMESCO Finland
Laparoscopic repair of inguinal hernia
1290.2
323.0
1100
12
K40.0
ICD-10 Finland
Bilateral inguinal hernia, with obstruction, without gangrene
+∞
323.0
418
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
194.4
323.0
1796
176
ZXA10
NOMESCO Finland
Bilateral
4.2
255.7
1197
3774
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
52.3
237.1
286
59
K40
ICD-10 Finland
Inguinal hernia
32.2
234.6
314
106
D89
ICPC
Inguinal hernia
43.1
199.7
250
62
K40.3
ICD-10 Finland
Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
98.9
170.8
188
20
6123
FHL
Radical surgery
113.1
168.7
183
17
55099
ICD-8 Finland
Inguinal hernia without mention of obstruction
+∞
166.9
159
*
JAB10
NOMESCO Finland
Repair of inguinal hernia
180.1
165.1
172
10
JAB97
NOMESCO Finland
Other laparoscopic repair of inguinal hernia
+∞
154.2
147
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
40.3
139.6
177
46
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
26.5
138.0
194
77
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
180.0
117.1
122
7
JAF10
NOMESCO Finland
Repair of umbilical hernia
30.6
111.1
150
51
5509B
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]
+∞
105.7
101
*
K40.1
ICD-10 Finland
Bilateral inguinal hernia, with gangrene
+∞
104.6
100
*
5509A
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,MEDIALIS]
+∞
92.0
88
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
74.7
728
3388
N02BE01
ATC
paracetamol; systemic, rectal
2.1
72.9
3058
25382
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
123.9
57.0
61
5
K41.9
ICD-10 Finland
Unilateral or unspecified femoral hernia, without obstruction or gangrene
290.9
56.4
57
*
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
192.8
55.1
57
*
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
494.0
49.5
49
*
JAB91
NOMESCO Finland
Repair of recurrent inguinal hernia, endoscopy
+∞
48.0
46
*
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
47.7
993
6176
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.3
47.1
503
2402
103
Kela drug reimbursment
Diabetes, insulin-treated
0.5
46.3
503
8682
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
+∞
43.8
42
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
42.9
1035
6711
5509D
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,RECIDIVANS]
+∞
42.8
41
*
6124
FHL
Radical cutting and plastic with foreign material
422.1
42.2
42
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.6
42.1
127
234
A10BA02
ATC
metformin; oral
0.5
41.1
545
8945
JAB93
NOMESCO Finland
Repair of recurrent inguinal hernia, implantation
+∞
40.7
39
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
+∞
36.5
35
*
ZXA00
NOMESCO Finland
Right side
1.7
34.8
916
6026
G04CA02
ATC
tamsulosin; oral
1.6
34.5
1388
10207
WX402
NOMESCO Finland
General anaesthesia
1.9
34.1
557
3141
JAB96
NOMESCO Finland
Other repair of inguinal hernia
340.1
34.0
34
*
A98
ICPC
Health maint/preventive medicine
1.8
33.8
3329
30368
WX320
NOMESCO Finland
Spinalanesthesy
1.7
33.6
755
4732
N40
ICD-10 Finland
Hyperplasia of prostate
1.6
33.6
1329
9715
WX110
NOMESCO Finland
Local anesthesy
1.5
31.0
2142
17642
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
31.0
2947
26104
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
29.8
1458
11108
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.6
29.0
464
7364
D91
ICPC
Abdominal hernia other
11.2
27.0
51
46
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
0.6
25.5
473
7279
A02BC02
ATC
pantoprazole; systemic
1.4
25.4
2069
17285
ZXA05
NOMESCO Finland
Left side
1.6
24.7
830
5744
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
24.6
674
4427
J01MA02
ATC
ciprofloxacin; systemic
1.4
23.9
1380
10737
G04CA01
ATC
alfuzosin; oral
1.6
23.0
683
4572
JAF11
NOMESCO Finland
Laparoscopic repair of umbilical hernia
+∞
22.9
22
*
S18
ICPC
Laceration/cut
1.4
22.6
1408
11085
J01CA04
ATC
amoxicillin; systemic
1.4
22.0
2501
21926
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
21.4
849
6076
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
21.0
292
1539
WX002
NOMESCO Finland
Sedation and analgesia
1.6
20.9
601
3984
J01AA02
ATC
doxycycline; systemic
1.4
20.6
2497
21988
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.4
20.6
72
1883
6125
FHL
Residual surgery, can be reported as a side effect
211.0
20.6
21
*
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.2
20.4
210
976
T90
ICPC
Diabetes non-insulin dependent
0.6
20.3
471
6940
A10BB12
ATC
glimepiride; oral
0.4
20.2
89
2122
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.6
20.1
523
3370
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
20.1
697
4830
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.4
19.6
1534
12477
XKD00
NOMESCO Finland
Uroflowmetry
1.5
19.6
858
6256
A02BC05
ATC
esomeprazole; systemic
1.4
19.1
1136
8794
K40.4
ICD-10 Finland
Unilateral or unspecified inguinal hernia, with gangrene
+∞
18.8
18
*
N02AX02
ATC
tramadol; systemic, rectal
1.4
18.7
1392
11200
A10AE04
ATC
insulin glargine; parenteral
0.5
18.4
119
2474
J01DB01
ATC
cefalexin; oral
1.4
18.4
2683
24109
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
18.0
430
2703
UKC02
NOMESCO Finland
Cystoscopy
1.5
17.9
687
4858
WX704
NOMESCO Finland
Intubation
2.0
17.8
230
1178
K41.2
ICD-10 Finland
Bilateral femoral hernia, without obstruction or gangrene
+∞
17.7
17
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
17.3
1074
8348
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
17.1
600
4149
ZXC86
NOMESCO Finland
Use of endoscopic device
8.5
17.1
37
44
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
17.1
848
6314
J01FA10
ATC
azithromycin; systemic
1.4
16.6
1474
12135
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.6
16.1
458
3013
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
0.4
16.0
57
1480
5509X
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,ALIA SEU NUD]
+∞
15.6
15
*
UJF32
NOMESCO Finland
Coloscopy
1.4
15.3
783
5850
M79.6
ICD-10 Finland
Pain in limb
1.4
15.1
944
7308
JAD10
NOMESCO Finland
Repair of incisional hernia
23.4
15.1
21
9
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.8
14.8
49
104
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
31.8
14.8
19
6
R01AD12
ATC
fluticasone furoate; nasal
1.5
14.8
639
4615
JAB40
NOMESCO Finland
Repair of inguinal hernia by laparotomy and reconstruction of abdominal wall
80.4
14.6
16
*
B01AB05
ATC
enoxaparin; parenteral
1.4
14.6
919
7122
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.5
14.5
116
477
SPAT1153
SPAT
Removal of sutures
1.4
13.6
1017
8089
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.3
13.4
29
941
K42
ICD-10 Finland
Umbilical hernia
7.7
13.3
30
39
A10BB01
ATC
glibenclamide; oral
0.4
13.1
42
1137
XJH00
NOMESCO Finland
Transanal ultrasonography
1.6
13.1
329
2093
M01AC06
ATC
meloxicam; systemic, rectal
1.3
13.0
965
7654
A10AE05
ATC
insulin detemir; parenteral
0.4
12.9
48
1224
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
12.6
691
5205
R42
ICD-10 Finland
Dizziness and giddiness
1.4
12.4
596
4380
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
3.8
12.2
51
137
M25.5
ICD-10 Finland
Pain in joint
1.4
12.2
658
4944
R03DC03
ATC
montelukast; oral
1.6
12.1
330
2141
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.3
12.1
1418
11997
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
0.6
12.0
157
2656
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
11.9
652
4907
E11
ICD-10 Finland
Type 2 diabetes mellitus
0.7
11.9
297
4354
R06AX27
ATC
desloratadine; oral
1.4
11.8
543
3958
R51.80
ICD-10 Finland
Headache
1.6
11.8
291
1842
R4110
NOMESCO Finland
Physiotherapy
1.4
11.6
783
6105
M01AE02
ATC
naproxen; oral, rectal
1.3
11.5
1558
13395
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
11.5
360
2420
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
11.3
601
4495
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
11.2
510
3703
AA1AD
NOMESCO Finland
CT of head and brain
1.4
11.2
764
5961
H02AB06
ATC
prednisolone; systemic
1.3
11.2
1405
11953
R03AC02
ATC
salbutamol; inhalant
1.3
11.1
1383
11748
J45
ICD-10 Finland
Asthma
1.7
11.0
212
1251
R01AD09
ATC
mometasone; nasal
1.3
10.9
1072
8819
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
0.3
10.9
29
850
R35
ICD-10 Finland
Polyuria
1.7
10.9
238
1458
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
10.8
196
1136
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
0.5
10.6
93
1760
K44.0
ICD-10 Finland
Diaphragmatic hernia with obstruction, without gangrene
60.1
10.6
12
*
M03BX02
ATC
tizanidine; oral
1.3
10.6
1680
14679
R20.2
ICD-10 Finland
Paraesthesia of skin
1.9
10.6
149
791
J01FA09
ATC
clarithromycin; systemic
1.3
10.6
759
5962
D01
ICPC
Abdominal pain/cramps general
1.7
10.5
225
1370
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
10.5
206
1222
D06
ICPC
Abdominal pain localized other
1.8
10.5
168
934
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
10.5
520
3839
55120
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Hernia epigastrica
+∞
10.4
10
*
A10AA02
ATC
NA
0.3
10.3
17
628
J01FA06
ATC
roxithromycin; oral
1.3
10.3
1072
8876
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
10.3
600
4558
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
10.3
302
1997
M01AB05
ATC
diclofenac; systemic, rectal
1.3
10.2
1993
17817
I83.9
ICD-10 Finland
Varicose veins of lower extremities without ulcer or inflammation
1.7
10.1
197
1168
M01AH05
ATC
etoricoxib; oral
1.3
10.1
1612
14069
WZC30
NOMESCO Finland
Teaching
1.5
10.0
393
2772
N06AX11
ATC
mirtazapine; oral
1.3
10.0
796
6342
WX290
NOMESCO Finland
Other blockade of nerve
1.3
9.8
1094
9127
A10BK03
ATC
empagliflozin; oral
0.5
9.7
92
1702
R05
ICD-10 Finland
Cough
1.4
9.6
477
3523
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
9.6
1109
9297
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.1
9.6
100
474
JBB01
NOMESCO Finland
Laparoscopic repair of paraoesophageal hernia
100.2
9.4
10
*
JAC30
NOMESCO Finland
Repair of femoral hernia using prosthetic material
+∞
9.4
9
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
9.4
696
5487
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.8
9.3
56
200
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
9.2
722
5736
L82
ICD-10 Finland
Seborrhoeic keratosis
1.4
9.1
407
2942
R53
ICD-10 Finland
Malaise and fatigue
1.4
9.0
521
3946
JA1AE
SPAT
NA
9.0
9.0
18
20
SPAT1262
SPAT
Handing over of treatment supplies
0.7
9.0
381
5102
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.4
9.0
400
2892
A02BC03
ATC
lansoprazole; oral
1.3
9.0
790
6377
M02AA07
ATC
piroxicam; topical
1.3
9.0
1008
8398
I49.3
ICD-10 Finland
Ventricular premature depolarization
1.7
9.0
193
1179
KED22
NOMESCO Finland
Transurethral resection of prostate
1.5
8.9
294
1999
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
8.8
969
8047
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
8.8
419
3067
A10BJ06
ATC
semaglutide; parenteral
0.3
8.8
16
565
H02AB04
ATC
methylprednisolone; systemic
1.5
8.8
355
2515
A10BH01
ATC
sitagliptin; oral
0.6
8.8
160
2508
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.6
8.8
219
1393
R33
ICD-10 Finland
Retention of urine
1.5
8.7
346
2444
R55
ICD-10 Finland
Syncope and collapse
1.5
8.7
347
2452
XF404
NOMESCO Finland
Ambulatory ECG
1.5
8.7
295
2019
Z02.4
ICD-10 Finland
Examination for driving licence
1.3
8.7
972
8089
JAC10
NOMESCO Finland
Repair of femoral hernia
50.1
8.7
10
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
8.6
204
1283
A10BG03
ATC
pioglitazone; oral
0.3
8.6
16
554
M79.1
ICD-10 Finland
Myalgia
1.5
8.5
260
1740
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.8
8.4
128
703
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
8.4
1122
9536
F51.0
ICD-10 Finland
Nonorganic insomnia
1.5
8.4
248
1645
5530A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Femoral hernia
+∞
8.3
8
*
R31
ICD-10 Finland
Unspecified haematuria
1.4
8.3
401
2944
N41.1
ICD-10 Finland
Chronic prostatitis
1.9
8.2
112
593
A02BC04
ATC
rabeprazole; oral
1.7
8.2
175
1068
L02
ICPC
Back symptom/complaint
1.7
8.1
180
1111
K59.09
ICD-10 Finland
Constipation, unspecified
1.7
8.1
173
1053
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
1.6
8.1
183
1136
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.5
8.1
267
1816
Z01.7
ICD-10 Finland
Laboratory examination
1.5
8.1
281
1932
R07.3
ICD-10 Finland
Other chest pain
1.5
8.1
240
1595
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
0.3
8.0
14
499
R03BA08
ATC
ciclesonide; inhalant
1.7
7.9
166
1008
SAA01
NOMESCO Finland
Simple examination of mouth
1.2
7.9
1927
17427
D01BA02
ATC
terbinafine; oral; topical
1.3
7.9
808
6642
R03AK07
ATC
formoterol and budesonide; inhalant
1.4
7.8
443
3344
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
1.8
7.8
132
755
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.3
7.8
22
626
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
7.8
778
6376
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.7
7.7
151
900
KMAK
NOMESCO Finland
NA
1.2
7.7
1320
11501
WX702
NOMESCO Finland
Supraglottic ventilation device
1.9
7.7
108
577
R03BA01
ATC
beclometasone; inhalant
1.4
7.7
324
2319
XF402
NOMESCO Finland
ECG with work load test
1.4
7.6
346
2514
J01DA01
ATC
[U] cefalexin; systemic
1.2
7.6
1841
16618
6129
FHL
Other measure in this category
11.8
7.6
13
11
A10BB07
ATC
glipizide; oral
0.1
7.6
*
298
U02
ICPC
Urinary frequency/urgency
1.5
7.5
222
1471
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
0.4
7.5
36
829
I34.1
ICD-10 Finland
Mitral (valve) prolapse
2.0
7.5
94
482
TKE00
NOMESCO Finland
Needle biopsy of prostate
1.6
7.5
202
1314
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.5
7.4
226
1514
J01MA06
ATC
norfloxacin; oral
1.5
7.4
268
1862
J31.0
ICD-10 Finland
Chronic rhinitis
1.6
7.3
167
1039
N01
ICPC
Headache
1.7
7.3
159
978
R63.4
ICD-10 Finland
Abnormal weight loss
1.9
7.3
103
553
JAH01
NOMESCO Finland
Laparoscopy
2.1
7.3
77
370
55121
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Alia hernia ventralis (incisionalis, in cicactrice)
+∞
7.3
7
*
JAC11
NOMESCO Finland
Laparoscopic repair of femoral hernia
+∞
7.3
7
*
I49.4
ICD-10 Finland
Other and unspecified premature depolarization
2.0
7.3
90
460
A02BC01
ATC
omeprazole; systemic
1.3
7.3
764
6293
I73.0
ICD-10 Finland
Raynaud syndrome
2.9
7.3
40
137
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
2.0
7.2
81
400
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
1.5
7.1
210
1395
A98
ICD-10 Finland
Other viral haemorrhagic fevers, not elsewhere classified
2.3
7.1
60
262
WX220
NOMESCO Finland
Ilioinguinal plexus blockade
10.0
7.0
13
13
J01EA01
ATC
trimethoprim; systemic
1.3
7.0
445
3421
R06AE09
ATC
levocetirizine; oral
1.5
7.0
269
1890
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
7.0
443
3404
PHD99
NOMESCO Finland
Resection of other vein
1.8
6.9
115
652
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
6.9
148
906
R21
ICPC
Throat symptom/complaint
1.4
6.9
339
2495
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.9
1239
10821
A01AB09
ATC
miconazole; local oral
1.6
6.9
186
1209
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
0.4
6.9
24
625
N43.3
ICD-10 Finland
Hydrocele, unspecified
1.9
6.9
91
477
L12
ICPC
Hand/finger symptom/complaint
1.4
6.9
313
2275
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.4
6.9
379
2849
H02AB07
ATC
prednisone; oral
1.4
6.9
362
2701
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
6.8
495
3878
A10BD07
ATC
metformin and sitagliptin; systemic
0.5
6.8
58
1101
N17
ICPC
Vertigo/dizziness
1.5
6.8
255
1788
N43.4
ICD-10 Finland
Spermatocele
2.0
6.8
84
432
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.8
644
5235
N30.0
ICD-10 Finland
Acute cystitis
1.5
6.7
229
1573
A02BA02
ATC
ranitidine; systemic
1.3
6.7
533
4228
WX720
NOMESCO Finland
Own respiration
1.8
6.7
109
615
J20
ICD-10 Finland
Acute bronchitis
1.5
6.7
211
1426
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.5
6.6
201
1345
P07.3
ICD-10 Finland
Other preterm infants
7.8
6.6
14
18
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.4
6.6
261
1848
R74
ICPC
Upper respiratory infection acute
1.3
6.6
500
3945
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
6.6
692
5694
K50.9
ICD-10 Finland
Crohn disease, unspecified
2.7
6.5
40
147
D03
ICPC
Heartburn
2.1
6.5
66
310
XF400
NOMESCO Finland
ECG with 12 standard connections
1.3
6.5
530
4220
R03BA05
ATC
fluticasone; inhalant
1.3
6.5
406
3110
N03AX16
ATC
pregabalin; oral
1.3
6.5
585
4720
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
6.5
268
1912
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
1.6
6.4
164
1053
B01AA03
ATC
warfarin; systemic
1.3
6.4
745
6200
R01BA52
ATC
pseudoephedrine, combinations; oral
1.3
6.4
654
5358
UJH02
NOMESCO Finland
Anoscopy
1.8
6.4
101
565
C05AA08
ATC
fluocortolone; rectal, topical
1.4
6.4
355
2669
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.2
6.4
1471
13132
R06AE07
ATC
cetirizine; oral
1.2
6.4
949
8118
R13
ICD-10 Finland
Dysphagia
1.6
6.4
170
1106
H01.0
ICD-10 Finland
Blepharitis
1.8
6.3
106
606
G04BD12
ATC
mirabegron; oral
1.4
6.3
271
1950
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.3
158
1014
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
1.3
6.3
407
3138
R01AD08
ATC
fluticasone; nasal
1.3
6.3
622
5079
J05AB01
ATC
aciclovir; systemic
1.3
6.3
453
3545
L17
ICPC
Foot/toe symptom/complaint
1.3
6.3
631
5165
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
6.2
240
1688
55110
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Umbilical
+∞
6.2
6
*
JAB95
NOMESCO Finland
Operation of inguinal hernia, removal of mesh due to complication
+∞
6.2
6
*
5531A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Umbilical hernia
+∞
6.2
6
*
D11
ICPC
Diarrhoea
1.5
6.2
207
1415
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
26.7
6.2
8
*
H3603, E113
ICD-10 Finland
NA
0.1
6.2
*
187
M20.1
ICD-10 Finland
Hallux valgus (acquired)
1.7
6.2
112
654
A10BX02
ATC
repaglinide; oral
0.1
6.2
*
233
D22.9
ICD-10 Finland
Melanocytic naevi, unspecified
1.8
6.2
92
507
R03DC01
ATC
zafirlukast; oral
2.6
6.2
41
158
WX725
NOMESCO Finland
Noninvasive ventilation
1.7
6.2
127
770
R03BB04
ATC
tiotropium bromide; inhalant
1.4
6.1
329
2458
J02AC01
ATC
fluconazole; systemic
1.3
6.1
608
4966
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
6.1
857
7287
M01AX17
ATC
nimesulide; oral
1.3
6.1
647
5333
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.5
6.1
229
1606

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2096
15171
1.76
68.33
4.0
4.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
2576
21061
1.57
42.49
4.8
4.3
e6/l
116.4
1069.1
1.95
54
403
(40761511) CBC panel - Blood by Automated count
3675
33395
1.78
33.90
16.8
15.5
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1398
10389
1.52
32.92
2.7
2.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
3732
34136
1.81
32.72
21.7
19.5
mmol/l
4.0
4.0
1.26
3652
33223
(3019550) Sodium [Moles/volume] in Serum or Plasma
3724
34044
1.80
32.67
21.5
19.4
mmol/l
139.6
139.6
0.26
3647
33176
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1121
7960
1.56
32.47
2.5
2.6
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
3873
35881
1.98
32.06
26.4
23.5
e9/l
6.8
7.0
5.83
3771
34713
(3044889) 12 lead EKG panel
2778
23763
1.50
31.93
4.6
4.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3870
35854
1.97
31.88
26.4
23.5
e9/l
230.0
233.7
3.08
3781
34825
(3024731) MCV [Entitic volume]
3870
35868
1.96
31.63
26.3
23.4
fl
91.7
91.5
2.86
3820
35259
(3026361) Erythrocytes [#/volume] in Blood
3870
35871
1.96
31.58
26.4
23.5
e12/l
4.5
4.5
1.31
3764
34712
(3035941) MCH [Entitic mass]
3869
35863
1.96
31.50
26.3
23.4
pg
30.6
30.6
2.28
3821
35256
(3000963) Hemoglobin [Mass/volume] in Blood
3870
35877
1.96
31.47
26.6
23.6
g/l
137.6
137.8
0.42
3822
35266
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3576
32452
1.67
30.59
18.2
16.3
mg/l
28.7
28.2
0.31
2907
26340
(3037467) Urinalysis macro (dipstick) panel - Urine
2632
22442
1.46
29.41
4.6
4.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3003
26292
1.49
29.17
21.9
19.6
%
13.7
13.8
4.12
2954
25685
(3003338) MCHC [Mass/volume]
3030
26616
1.49
28.60
23.6
20.6
g/l
333.7
333.7
0.09
3002
26383
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
2238
18638
1.43
27.54
4.6
4.4
%
22.4
22.1
0.57
1168
9506
(3033658) Prothrombin time (PT) actual/Normal
1173
8683
1.49
27.01
4.4
4.2
%
83.3
83.3
0.01
1148
8497
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
2711
23428
1.44
26.85
5.2
5.1
ug/l
2.7
3.3
1.99
2434
21005
(3011397) Hemoglobin [Presence] in Urine by Test strip
994
7201
1.50
25.16
4.0
3.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
1910
15674
1.40
24.37
3.7
3.4
estimate
0.0
0.0
0.50
320
3100
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1884
15453
1.40
23.97
7.2
6.7
mmol/l
1.2
1.2
0.16
1737
14016
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2906
25657
1.43
23.94
8.3
7.9
u/l
76.4
80.9
5.95
2738
24198
(36304419) Bacteria [Presence] in Urine
1267
9720
1.43
23.55
3.7
3.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1560
12453
1.40
23.01
4.3
3.9
e6/l
62.0
93.5
1.71
1168
9441
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3719
34623
1.63
22.51
11.7
10.8
u/l
26.8
28.6
1.22
3594
33257
(3013826) Glucose [Moles/volume] in Serum or Plasma
2424
20873
1.38
22.24
5.4
5.2
mmol/l
6.5
7.0
29.04
2294
19655
(3021601) Nitrite [Presence] in Urine by Test strip
1889
15627
1.38
22.22
5.0
4.6
estimate
0.0
0.0
0.50
325
3183
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3126
28106
1.43
22.18
4.2
3.9
mu/l
2.0
2.1
1.13
2827
25205
(3009261) Glucose [Presence] in Urine by Test strip
1906
15832
1.37
21.66
3.8
3.5
estimate
0.0
0.0
0.69
313
2971
(3009542) Hematocrit [Volume Fraction] of Blood
3184
28787
1.43
21.37
19.8
17.1
%
40.4
40.0
1.53
2206
19160
(3024561) Albumin [Mass/volume] in Serum or Plasma
1799
14859
1.37
20.94
5.5
5.3
g/l
35.0
34.8
0.79
1689
13796
(3013650) Neutrophils [#/volume] in Blood by Automated count
2211
18869
1.36
20.84
9.1
9.1
e9/l
4.2
4.4
3.44
1898
16356
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
860
6267
1.47
20.57
3.2
3.0
e6/l
0.7
1.0
1.71
484
3766
(3013707) Erythrocyte sedimentation rate by Westergren method
2673
23594
1.36
19.73
4.2
3.9
mm/h
11.3
13.1
7.15
2471
21664
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3431
31594
1.46
19.65
4.7
4.9
mmol/l
5.9
6.2
34.19
3129
28487
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2080
17712
1.34
19.24
6.7
6.6
umol/l
12.5
13.0
1.31
1976
16870
(3002582) Erythrocytes [#/volume] in Urine
1404
11259
1.37
19.22
3.7
3.4
e6/l
91.5
99.8
0.14
1101
8912
(3018418) pH of Serum or Plasma
1254
9878
1.38
19.17
4.4
4.4
ph
7.4
7.4
0.02
198
2050
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
452
2908
1.62
19.04
2.6
2.5
u/l
41.5
55.8
0.37
401
2503
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3336
30618
1.43
18.91
17.0
15.6
ml/min/173m2
77.3
77.1
0.23
2810
25483
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1525
12417
1.36
18.85
3.2
2.8
ug/l
167.7
191.3
1.27
1395
11363
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
803
5881
1.45
18.49
3.4
3.4
mmol/l
2.4
2.5
5.32
711
5141
(40768804) Tissue Pathology biopsy report
1489
12127
1.35
18.21
2.2
2.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
1623
13392
1.34
18.20
3.1
3.1
ug/l
0.8
0.8
0.76
1135
9256
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3521
32746
1.46
17.62
5.2
5.2
mmol/l
2.6
2.6
0.88
3236
29960
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
797
5919
1.43
16.85
3.5
3.2
e6/l
1.0
1.0
0.01
425
3445
(3000850) Epithelial cells [#/volume] in Urine
1012
7838
1.38
16.74
2.7
2.7
e6/l
2.8
3.3
1.59
888
6907
(3030467) Casts [#/volume] in Urine by Automated count
1271
10216
1.35
16.58
3.7
3.3
e6/l
0.3
0.4
4.43
976
7885
(40758558) Short blood count panel - Blood
1032
8030
1.38
16.57
7.5
6.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1967
16864
1.31
16.24
2.6
2.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2449
21649
1.31
16.09
3.4
3.2
pmol/l
15.0
14.9
0.94
2188
19317
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1986
17063
1.31
16.09
7.9
7.5
mmol/l
1.2
1.2
0.54
1701
14334
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
928
7129
1.39
16.03
4.2
4.0
ng/l
610.2
732.5
0.27
799
6056
(3019150) Specific gravity of Urine by Refractometry
894
6840
1.39
15.80
4.4
3.8
kg/l
1.0
1.0
0.49
104
1023
(40761535) Cells panel - Urine sediment
432
2883
1.56
15.47
3.5
3.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1951
16854
1.29
14.64
6.3
5.9
e9/l
1.8
2.0
1.67
1684
14699
(3015377) Calcium [Moles/volume] in Serum or Plasma
1297
10616
1.32
14.52
3.7
3.5
mmol/l
2.3
2.3
2.09
1150
9210
(3006315) Basophils [#/volume] in Blood
1916
16528
1.29
14.47
6.3
5.8
e9/l
0.0
0.0
1.62
1633
14184
(3001604) Monocytes [#/volume] in Blood
1905
16423
1.29
14.45
6.3
5.8
e9/l
0.6
0.6
5.32
1620
14077
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
715
5341
1.41
14.41
1.2
1.2
u/ml
1.3
2.2
1.96
182
1397
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1393
11574
1.30
13.82
2.3
2.1
nmol/l
78.2
76.1
1.84
1232
10237
(3013115) Eosinophils [#/volume] in Blood
1959
17034
1.28
13.57
6.5
6.1
e9/l
0.2
0.2
1.87
1696
14804
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3421
32010
1.36
13.47
4.6
4.7
mmol/l
4.4
4.3
0.34
3148
29473
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1658
14147
1.28
13.25
2.1
2.0
pmol/l
92.0
91.7
0.10
895
8087
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1318
10950
1.30
12.88
2.3
2.2
u/l
229.5
264.1
0.61
1247
10248
(40768797) Stomach Pathology biopsy report
543
3936
1.44
12.86
1.3
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3390
31761
1.34
12.56
4.5
4.7
mmol/l
1.4
1.3
5.90
3091
29022
(3048689) Calprotectin [Mass/mass] in Stool
416
2922
1.47
11.60
2.5
2.4
ug/g
111.7
172.3
5.64
322
2338
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1438
12218
1.27
11.42
4.0
3.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
561
4188
1.39
11.16
1.9
1.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
866
6926
1.31
10.94
1.8
1.8
nmol/l
1175.5
1140.9
0.43
650
5209
(3014576) Chloride [Moles/volume] in Serum or Plasma
653
5016
1.36
10.86
7.3
7.3
mmol/l
104.9
104.6
1.04
646
4898
(3026782) Osmolality of Urine
913
7370
1.30
10.75
2.9
2.9
mosm/kgh2o
579.2
580.9
0.08
763
6321
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
3274
30719
1.29
10.63
5.6
6.6
mmol/mol
39.0
41.2
49.11
3020
28269
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
558
4200
1.38
10.53
1.9
1.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1800
15802
1.24
10.48
11.2
10.9
inr
1.4
1.3
0.81
436
4492
(3029937) Albumin [Presence] in Urine by Test strip
1060
8763
1.28
10.33
4.4
3.8
estimate
0.0
0.0
1.74
308
2907
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1063
8791
1.28
10.33
2.3
2.2
mg/l
3.0
3.0
0.10
902
7465
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3278
30798
1.29
10.29
4.1
4.2
mmol/l
1.2
1.3
18.85
2975
27946
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
843
6775
1.31
10.20
1.8
1.8
mg/l
1.3
1.4
0.47
650
5310
(3022096) Basophils/100 leukocytes in Blood
1725
15112
1.24
10.12
6.5
6.1
%
0.7
0.6
0.51
1608
14119
(3026008) Bacteria identified in Urine by Culture
1045
8652
1.28
10.01
3.0
3.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
496
3694
1.39
9.97
2.9
2.9
umol/l
8.1
10.3
2.01
441
3283
(42870588) Differential panel, method unspecified - Blood
1355
11582
1.25
9.87
6.5
5.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1243
10531
1.26
9.77
2.8
2.6
u/l
60.7
59.3
0.44
1157
9772
(3000991) Gas panel - Venous blood
457
3368
1.40
9.77
8.8
8.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
555
4251
1.35
9.33
9.1
7.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
650
5097
1.33
9.32
1.4
1.5
g/l
2.6
2.8
1.80
372
3191
(3006504) Eosinophils/100 leukocytes in Blood
1761
15557
1.23
9.28
6.5
6.1
%
2.8
2.9
0.49
1639
14507
(3027945) Reticulocytes/100 erythrocytes in Blood
602
4679
1.33
9.17
2.6
2.5
%
1.7
1.7
1.08
521
4146
(3019069) Monocytes/100 leukocytes in Blood
1766
15645
1.22
8.95
6.7
6.4
%
9.2
9.0
1.06
1644
14646
(4010399)
326
2297
1.45
8.93
1.5
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
994
8290
1.26
8.79
1.6
1.6
nmol/l
19.9
19.2
0.52
871
7103
(3014111) Lactate [Moles/volume] in Serum or Plasma
463
3479
1.37
8.79
7.4
7.4
mmol/l
1.3
1.4
1.16
440
3333
(3018010) Neutrophils/100 leukocytes in Blood
1766
15690
1.22
8.57
6.4
6.0
%
58.5
58.4
0.14
1649
14675
(3022217) INR in Platelet poor plasma by Coagulation assay
675
5383
1.30
8.52
33.2
27.6
inr
1.4
1.5
0.24
56
803
(3002030) Lymphocytes/100 leukocytes in Blood
1795
15983
1.21
8.49
6.6
6.2
%
26.1
26.1
0.06
1672
14864
(3000494) Fungus identified in Specimen by Culture
500
3846
1.34
8.14
1.5
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2275
20799
1.20
7.95
3.1
3.2
u/l
50.0
59.6
6.33
2128
19149
(36660697) Celiac disease serology panel - Serum
272
1896
1.46
7.90
1.2
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1051
8929
1.24
7.74
1.3
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
167
1055
1.61
7.64
1.0
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
590
4694
1.30
7.54
7.1
7.5
mmol/l
0.9
1.0
0.32
464
3612
(3027801) Oxygen [Partial pressure] in Arterial blood
590
4698
1.30
7.48
7.2
7.5
kpa
12.1
11.9
0.33
554
4462
(3003327) Ova and parasites identified in Stool by Light microscopy
131
782
1.70
7.48
1.6
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
590
4700
1.30
7.46
7.2
7.5
kpa
5.1
5.1
0.35
554
4469
(3002173) Hemoglobin [Mass/volume] in Arterial blood
493
3845
1.32
7.28
7.9
8.3
g/l
122.8
122.9
0.05
477
3694
(4034850)
160
1029
1.58
6.83
12.0
10.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1252
10941
1.21
6.81
4.8
4.6
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
465
3633
1.31
6.77
2.4
2.4
ug/l
8.4
8.5
0.02
414
3216
(3022145) Colonoscopy Study observation
455
3548
1.32
6.72
1.3
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1564
13963
1.19
6.70
4.1
3.9
ng/l
36.9
79.0
2.54
1141
10729
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
266
1911
1.42
6.61
4.3
4.3
mmol/l
23.8
24.0
0.49
231
1713
(3052851) Hemolysis interference index of Serum or Plasma
154
995
1.57
6.46
3.2
3.6
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
124
760
1.65
6.46
1.2
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
744
6201
1.24
6.41
2.2
2.1
s
30.1
30.3
0.36
716
6024
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
738
6149
1.24
6.37
2.0
1.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
713
5929
1.24
6.26
2.8
2.7
umol/l
12.6
12.8
0.23
675
5503
(3016502) Oxygen saturation in Arterial blood
534
4293
1.28
6.26
7.5
7.7
%
95.4
95.2
0.31
517
4115
(3021589) Normoblasts [#/volume] in Blood
1630
14668
1.18
6.24
11.3
10.6
e9/l
0.0
0.0
0.28
1318
12051
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
292
2157
1.38
6.18
9.7
9.8
mmol/l
24.2
24.2
0.07
257
2012
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
73
391
1.88
6.06
3.8
3.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
124
773
1.62
6.06
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
124
773
1.62
6.06
1.4
1.3
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
672
5571
1.25
6.06
2.8
2.7
g/l
2.2
2.3
0.37
623
5178
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
65
1197
0.54
5.99
2.1
2.3
ug/min
93.8
142.6
0.64
41
714
(3020682) Albumin/Creatinine [Ratio] in Urine
1117
12674
0.84
5.84
3.8
4.2
mg/mmol
9.7
11.7
0.54
721
8667
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
238
1721
1.41
5.73
2.5
2.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
296
2222
1.36
5.68
10.2
10.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
159
1068
1.51
5.64
1.4
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
233
1690
1.40
5.53
1.9
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
634
5276
1.24
5.50
3.0
2.8
%
22.8
22.6
0.10
539
4496
(3013139) Helicobacter pylori Ag [Presence] in Stool
229
1669
1.39
5.29
1.2
1.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
367
2875
1.30
5.26
3.0
2.7
ml/min/173m2
64.3
62.1
0.45
138
1142
(3002256) Pathology report gross observation
526
4318
1.25
5.16
1.4
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
185
1315
1.43
4.95
3.7
3.8
u/ml
316.5
1847.2
1.00
155
1139
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1189
10584
1.17
4.94
3.1
3.3
u/l
40.9
37.6
0.23
1124
10005
(3000492) Spirometry study
367
2902
1.29
4.91
1.5
1.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
572
4796
1.22
4.60
4.6
4.4
u/l
239.1
247.8
0.45
528
4541
(3012516) Albumin [Mass/volume] in Urine
1069
11980
0.86
4.57
3.2
3.4
mg/l
308.7
304.3
0.01
700
8260
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
423
3435
1.26
4.57
1.4
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
440
3595
1.25
4.50
3.1
2.6
e9/l
66.0
68.9
0.84
322
2782
(46235355) HIV 1 and 2 tests - Meaningful Use set
494
4105
1.23
4.33
1.8
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
115
767
1.51
4.30
1.2
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
115
772
1.50
4.19
1.2
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
491
4095
1.23
4.16
1.8
1.9
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1262
11422
1.15
4.06
3.1
3.2
ng/l
1706.5
1702.3
0.01
1096
9964
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
174
1271
1.38
4.05
3.5
3.6
pmol/l
4.5
4.4
0.20
154
1128
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
113
765
1.49
3.97
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
281
2213
1.29
3.93
1.9
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
46
249
1.86
3.83
1.7
2.3
e6/l
678.1
585.6
0.19
14
102
(44790049)
67
406
1.66
3.80
1.7
1.5
—
—
—
0
0
(44790048)
67
406
1.66
3.80
1.7
1.5
—
—
—
0
0
(44790047)
67
406
1.66
3.80
1.7
1.5
—
—
—
0
0
(44806118)
67
406
1.66
3.80
1.7
1.5
—
—
—
0
0
(3020891) Body temperature
208
1580
1.33
3.79
4.8
5.0
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
86
555
1.56
3.78
1.4
1.4
mmol/l
68.2
65.4
0.24
69
449
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
15
50
3.01
3.68
1.0
1.4
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
127
897
1.43
3.62
1.4
1.5
ug/g
293.0
250.2
0.34
73
568
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
279
2222
1.27
3.59
1.5
1.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
302
2431
1.26
3.56
10.1
7.8
mmol/l
24.6
24.7
0.12
302
2409
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
398
3304
1.23
3.55
2.4
2.3
g/l
0.2
0.2
0.34
366
3077
(3024928) Oxygen saturation in Venous blood
121
853
1.43
3.50
2.9
3.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
51
295
1.74
3.45
1.1
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
196
1499
1.32
3.44
2.9
2.7
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
294
2377
1.25
3.35
5.0
4.6
ng/l
92.7
105.1
1.46
266
2075
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
128
921
1.40
3.32
1.6
1.7
iu/ml
0.3
6.5
0.61
26
207
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
201
1552
1.31
3.30
1.9
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
126
907
1.40
3.26
1.2
1.2
u/ml
3.3
0.6
0.76
17
80
(3002032) Base excess in Venous blood by calculation
452
3838
1.20
3.21
4.1
4.1
mmol/l
1.6
1.8
0.68
366
3073
(3000093) Morphology [Interpretation] in Blood Narrative
63
394
1.61
3.21
1.1
1.1
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
248
1976
1.27
3.21
1.5
1.7
g/l
1.4
1.6
1.00
206
1705
(3049717) Cytology report of Urine Cyto stain
247
1968
1.27
3.20
2.8
2.9
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
151
1124
1.36
3.20
1.7
1.6
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
14
49
2.86
3.18
4.5
6.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
18
402
0.45
3.10
1.9
2.1
ml
782.9
652.2
0.81
13
255
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
290
1.70
3.10
1.1
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
188
1454
1.31
3.08
1.3
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
318
2622
1.23
3.06
6.0
7.0
mmol/l
24.6
24.4
0.23
304
2443
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
510
4399
1.18
3.04
1.3
1.2
iu/ml
38.0
41.2
0.18
155
1320
(3009508) Creatinine [Moles/volume] in Urine
1131
12328
0.89
2.98
3.2
3.4
mmol/l
8.2
8.3
0.16
966
10268
(3017446) Testosterone [Moles/volume] in Serum or Plasma
499
4305
1.18
2.97
2.0
2.2
nmol/l
14.2
12.8
3.22
440
3790
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
234
1876
1.26
2.91
2.4
2.4
au/ml
22.8
17.6
0.26
14
74
(3003458) Phosphate [Moles/volume] in Serum or Plasma
585
5122
1.16
2.90
7.2
6.5
mmol/l
1.0
1.0
0.77
545
4794
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
214
1698
1.27
2.90
1.3
1.3
au/ml
80.2
62.1
0.28
11
72
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
84
575
1.47
2.89
1.4
1.5
u/ml
98.8
108.5
0.45
16
119
(3021447) Carbon dioxide [Partial pressure] in Venous blood
449
3852
1.19
2.86
4.1
4.1
kpa
5.9
5.8
0.58
430
3739
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
131
975
1.35
2.82
1.7
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
339
2843
1.21
2.78
3.9
4.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
9
23
3.92
2.77
2.7
2.3
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
157
1204
1.32
2.77
3.8
4.4
mmol/l
3.9
4.0
1.61
151
1123
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
122
903
1.36
2.73
1.8
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
84
583
1.45
2.72
2.5
2.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
62
928
0.66
2.67
4.3
3.6
mmol/l
7.8
7.8
0.01
62
904
(3020630) Protein [Mass/volume] in Serum or Plasma
391
3336
1.19
2.67
2.4
2.6
g/l
66.0
66.3
0.28
346
3047
(3051651) Icteric interference index of Serum or Plasma
37
212
1.75
2.66
3.7
4.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
118
875
1.36
2.62
2.5
2.8
%
201.3
204.4
0.14
109
838
(3023323) Follitropin [Units/volume] in Serum or Plasma
65
433
1.51
2.59
1.4
1.4
iu/l
17.6
19.2
0.17
55
348
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
31
170
1.83
2.58
1.1
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
54
346
1.57
2.56
3.6
3.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
215
1737
1.25
2.54
1.4
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
369
3148
1.19
2.53
3.7
3.4
kpa
4.4
4.6
0.94
352
3041
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
401
3446
1.18
2.53
3.0
3.0
ng/l
260.2
226.2
0.33
368
3177
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
20
95
2.11
2.48
1.2
1.3
nmol/l
169.4
155.9
0.10
12
71
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
100
730
1.38
2.47
1.5
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
147
1138
1.30
2.46
2.6
2.1
g/l
0.0
0.0
0.03
131
1039
(3042936) Bacteria identified in Isolate by Culture
593
5265
1.15
2.45
2.1
2.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
136
1048
1.31
2.36
2.8
2.2
g/l
0.0
0.0
0.00
120
964
(3042733) HLA Ab [Presence] in Serum
21
104
2.02
2.35
4.3
4.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
78
1088
0.71
2.34
4.0
4.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
129
989
1.31
2.33
2.4
2.5
%
88.2
87.6
0.10
121
948
(3048929) Epstein Barr virus Ab [Presence] in Serum
108
807
1.35
2.32
1.5
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
79
561
1.42
2.31
1.5
1.2
u/ml
270.6
294.7
0.32
47
358
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
37
222
1.67
2.30
1.6
2.5
e6/l
413.8
506.0
0.65
32
183
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
89
646
1.39
2.30
1.4
1.4
—
—
—
0
0
(3036489) Thrombin time
154
1212
1.28
2.29
2.2
2.3
s
21.8
21.9
0.09
137
1096
(3012095) Magnesium [Moles/volume] in Serum or Plasma
668
6005
1.13
2.29
3.6
3.5
mmol/l
0.8
0.8
0.85
626
5630
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
934
8566
1.12
2.28
1.6
1.7
mmol/l
1.3
1.4
6.74
788
7052
(3020779) Urea [Moles/volume] in Serum or Plasma
454
3979
1.16
2.26
8.3
7.4
mmol/l
10.4
11.0
0.74
433
3777
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
35
209
1.68
2.22
2.1
2.6
%
38.7
36.6
—
10
76
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
11
42
2.62
2.18
1.1
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
183
1481
1.25
2.17
2.6
2.3
ug/l
411.3
607.1
0.69
173
1415
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
440
3860
1.16
2.17
3.8
3.7
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
35
563
0.62
2.16
3.5
2.4
mmol/l
105.3
105.6
0.13
35
554
(3041354) Potassium [Moles/volume] in Venous blood
35
563
0.62
2.16
3.5
2.4
mmol/l
4.2
4.1
0.16
35
554
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
84
611
1.38
2.16
1.1
1.1
u/ml
0.9
11.1
—
8
60
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
36
219
1.65
2.15
1.9
2.0
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
130
1011
1.29
2.14
2.8
2.7
g/l
3.1
3.7
7.00
123
966
(3002619) Bacteria identified in Specimen by Culture
14
61
2.30
2.14
1.1
1.3
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
57
387
1.48
2.13
1.3
1.4
pmol/l
105.6
140.6
0.17
13
118
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
463
4084
1.15
2.12
1.2
1.2
u/ml
10.2
14.3
0.69
169
1516
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
174
1405
1.25
2.12
1.5
1.5
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
34
205
1.66
2.10
1.2
1.2
mmol/l
36.2
35.9
0.02
27
179
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
136
1067
1.28
2.10
2.8
2.2
g/l
0.0
0.0
0.00
120
968
(3020876) Protein [Mass/time] in 24 hour Urine
56
380
1.48
2.10
1.8
2.0
g/24h
0.9
1.4
—
5
12
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
5
10
5.00
2.07
5.0
5.5
umol/l
332.4
379.3
—
5
10
(4212803)
9
31
2.91
2.07
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
41
261
1.58
2.06
1.9
1.6
u/ml
18.3
29.7
1.31
12
57
(3033705) Calcium.ionized [Moles/volume] in Venous blood
35
555
0.63
2.05
3.5
2.4
—
—
—
0
0
(3036603) Volume of Urine
36
223
1.62
2.02
1.4
1.8
ml
1920.1
1907.4
—
8
69
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
11
44
2.50
2.01
1.3
1.8
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
44
2.50
2.01
1.9
2.1
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
148
1184
1.26
1.97
2.6
2.1
g/l
37.5
37.5
0.02
127
1012
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
134
1060
1.27
1.96
1.7
1.8
pmol/l
210.3
206.1
0.19
124
990
(3041096) Erythrocytes [Presence] in Urine by Automated
928
8575
1.11
1.96
3.3
3.3
—
—
—
0
0
(3014891) Appearance of Pleural fluid
15
71
2.12
1.92
1.8
1.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
82
608
1.36
1.91
1.6
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
34
211
1.62
1.91
1.6
1.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
219
1834
1.20
1.91
3.2
2.7
%
0.6
0.7
0.64
211
1758
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
74
540
1.38
1.90
4.0
2.8
u/ml
407.6
2323.8
—
7
36
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
121
951
1.28
1.88
1.9
1.7
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
160
1300
1.24
1.88
2.6
2.3
g/l
1.4
1.0
0.38
136
1107
(3045414) Leukocytes [Presence] in Urine
168
1373
1.23
1.87
1.9
1.8
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
63
449
1.41
1.86
1.8
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
117
917
1.28
1.86
2.0
1.8
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
25
144
1.74
1.84
29.4
33.9
ug/l
6.2
7.2
2.07
19
132
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
43
285
1.51
1.84
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
72
527
1.37
1.83
1.3
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
44
294
1.50
1.82
2.3
2.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
43
286
1.51
1.81
2.0
2.4
%
12.0
11.3
0.45
43
286
(40760892) CBC W Ordered Manual Differential panel - Blood
757
6953
1.11
1.80
4.6
4.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
79
589
1.35
1.80
1.7
1.5
e6/l
1228.6
2332.1
1.54
56
423
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
33
207
1.60
1.79
1.3
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
91
694
1.32
1.78
2.1
1.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
354
3106
1.15
1.78
1.8
1.6
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
80
599
1.34
1.77
1.5
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
61
838
0.72
1.75
1.2
1.5
nmol/l
0.8
0.9
0.61
47
699
(3019832) Treponema pallidum Ab [Presence] in Serum
169
1394
1.22
1.74
1.5
1.6
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
111
874
1.28
1.72
2.1
1.8
mg/l
11.0
11.5
0.32
105
813
(3003434) Protein [Mass/volume] in Pleural fluid
89
682
1.31
1.70
1.6
1.5
g/l
33.9
32.2
0.62
76
603
(4015189)
19
104
1.83
1.67
2.2
2.0
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
173
1438
1.21
1.66
2.5
2.2
g/l
10.6
10.4
0.25
144
1219
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
65
477
1.37
1.65
2.6
2.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
97
756
1.29
1.64
3.5
2.8
nmol/l
0.8
0.8
0.27
81
577
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
71
531
1.34
1.61
1.3
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
117
940
1.25
1.56
4.9
7.0
mmol/l
11.5
11.5
0.04
106
833
(3018572) Chloride [Moles/volume] in Blood
117
940
1.25
1.56
4.9
7.0
mmol/l
104.8
105.3
0.50
106
833
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
107
851
1.26
1.56
1.9
1.7
mg/l
4.8
3.2
0.40
66
605
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
185
1560
1.19
1.55
3.1
2.9
u/ml
0.4
0.3
0.22
92
905
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
75
570
1.32
1.54
1.8
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
21
122
1.72
1.54
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
18
100
1.80
1.52
1.1
1.0
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
302
2655
1.15
1.51
2.8
2.4
nmol/l
370.5
370.9
0.01
281
2461
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
17
93
1.83
1.51
1.1
1.0
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
92
722
1.28
1.50
7.5
5.6
iu/ml
598.3
3886.6
0.82
23
116
(3024471) HLA-A [Type]
19
108
1.76
1.50
1.1
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
314
2770
1.14
1.50
2.3
2.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
33
218
1.52
1.48
2.8
2.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
19
109
1.75
1.46
1.2
1.1
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
156
1304
1.20
1.45
4.6
6.1
mmol/l
1.2
1.4
2.84
139
1132
(3045462) Protein/Creatinine [Ratio] in Urine
9
38
2.37
1.45
3.6
7.5
g/mol
78.3
1554.4
—
9
30
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
14
73
1.92
1.43
1.1
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
147
1224
1.21
1.43
1.2
1.2
iu/ml
222.4
132.0
1.04
49
413
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
252
2198
1.16
1.42
2.2
1.9
—
—
—
0
0
(3022313) Gas panel - Capillary blood
173
2036
0.84
1.42
9.1
4.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
132
1089
1.22
1.41
4.9
3.5
mg/l
1.7
1.7
0.01
126
994
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
112
909
1.24
1.40
1.3
1.4
g/l
1.1
1.2
0.81
106
868
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
52
380
1.37
1.40
2.1
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
55
406
1.36
1.39
1.1
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
181
1542
1.18
1.38
1.2
1.3
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
107
866
1.24
1.38
1.5
1.5
e6/l
9830.9
20115.7
2.79
82
617
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
371
3331
1.12
1.37
1.6
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
89
706
1.27
1.36
2.2
2.1
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
5
17
2.94
1.36
1.4
1.7
umol/l
1.5
1.4
—
5
17
(3024263) Appearance of Synovial fluid
30
199
1.51
1.34
1.2
1.5
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
38
0.00
1.34
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
39
0.00
1.33
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
13
68
1.91
1.33
2.2
1.7
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
87
691
1.26
1.32
1.6
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
48
350
1.38
1.32
2.2
2.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
24
152
1.58
1.31
1.0
1.1
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
114
935
1.23
1.31
2.3
2.2
g/l
131.1
130.4
0.10
85
688
(3023410) Appearance of Cerebral spinal fluid
40
283
1.42
1.31
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
54
403
1.34
1.30
1.1
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
54
403
1.34
1.30
1.1
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
21
129
1.63
1.29
3.2
2.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
16
91
1.76
1.28
1.1
1.1
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
16
91
1.76
1.28
1.4
1.4
g/l
27.2
24.2
0.37
16
72
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
5
18
2.78
1.28
1.0
1.4
%
1.5
1.3
—
5
18
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
18
2.78
1.28
1.0
1.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
54
404
1.34
1.28
1.1
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
6
131
0.46
1.28
1.3
1.6
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
168
1435
1.18
1.27
2.6
2.2
g/l
2.9
3.0
0.56
135
1122
(3018851) Theophylline [Moles/volume] in Serum or Plasma
8
35
2.29
1.26
1.3
1.5
umol/l
57.0
42.9
—
8
35
(3005988) Vibrio sp identified in Specimen by Organism specific culture
54
405
1.34
1.26
1.1
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
55
414
1.33
1.26
1.1
1.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
404
3666
1.11
1.25
4.5
4.3
ug/l
6.5
26.2
4.12
327
3123
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
117
968
1.21
1.25
1.4
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
98
796
1.24
1.25
1.7
1.6
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
6
25
2.40
1.24
1.8
2.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
192
1663
1.16
1.22
2.2
1.5
u/ml
25.1
18.0
—
5
47
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
99
807
1.23
1.22
1.3
1.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
26
385
0.67
1.21
1.3
1.3
nmol/l
0.7
0.2
—
6
34
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
5
19
2.63
1.21
1.0
1.2
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
19
2.63
1.21
1.4
3.4
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
5
19
2.63
1.21
1.0
1.3
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
106
872
1.22
1.21
1.3
1.3
g/l
0.2
0.2
0.70
101
829
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
23
348
0.66
1.20
1.3
1.3
nmol/l
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
68
533
1.28
1.18
1.7
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
1063
10090
1.07
1.18
3.0
3.0
umol/l
4278.9
5893.7
0.64
930
8748
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
64
1.88
1.18
1.1
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
48
359
1.34
1.16
1.2
1.3
e6/l
135153.3
154086.9
0.08
33
249
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
0
33
0.00
1.16
0.0
1.1
—
0.4
—
0
21
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
17
102
1.67
1.16
1.1
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
120
1005
1.20
1.15
1.2
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
38
274
1.39
1.15
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
65
510
1.28
1.13
1.5
1.7
iu/l
4.3
4.4
0.03
14
152
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
26
175
1.49
1.12
2.1
2.0
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
61
476
1.29
1.11
2.0
1.6
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
66
830
0.79
1.10
4.3
3.6
u/ml
59.5
875.2
2.92
61
767
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
31
2.26
1.10
1.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
45
337
1.34
1.09
2.4
2.0
titre
512.0
770.5
—
5
19
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
5
21
2.38
1.09
6.6
8.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
22
144
1.53
1.08
2.6
2.5
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
183
1599
1.15
1.07
1.3
1.3
u/ml
193.2
345.7
2.34
169
1460
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
382
1.31
1.07
1.3
1.3
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
13
74
1.76
1.06
1.5
1.3
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
16
97
1.65
1.06
1.3
1.2
%
40.0
28.9
—
10
60
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
140
1628
0.86
1.06
2.3
2.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
61
480
1.27
1.05
1.5
1.3
u/l
328.7
412.2
0.42
54
453
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
15
241
0.62
1.05
2.7
2.0
ug/min
32.6
229.0
—
8
63
(3028308) Erythrocytes [#/volume] in Pleural fluid
68
543
1.26
1.04
1.7
1.5
e6/l
36282.8
76605.6
0.97
43
325
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
81
660
1.23
1.04
1.2
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
5
22
2.27
1.03
1.4
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
22
2.27
1.03
1.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
23
154
1.50
1.03
1.2
1.6
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
412
3787
1.10
1.03
1.3
1.3
titre
397.5
444.9
0.34
79
722
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
177
1549
1.15
1.02
2.5
2.2
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
31
221
1.41
1.02
1.3
1.3
—
97.1
—
0
21
(40761536) Microorganisms panel - Urine sediment
315
2859
1.11
1.01
4.1
3.9
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
177
1551
1.15
1.01
2.5
2.2
g/l
7.0
7.3
1.43
136
1148
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
176
1543
1.15
1.00
2.5
2.2
g/l
3.8
3.9
0.38
129
1105
(3021387) Prolactin [Units/volume] in Serum or Plasma
82
673
1.22
1.00
1.8
1.6
mu/l
312.5
272.5
0.52
76
632
(3008295) Osmolality of Serum or Plasma
45
343
1.32
0.99
1.3
1.4
mosm/kgh2o
277.8
284.1
0.88
35
266
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
115
1.57
0.99
5.7
7.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
710
1.22
0.99
1.6
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
57
449
1.27
0.99
3.4
3.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
255
2832
0.89
0.99
4.2
4.0
%
0.5
0.7
0.70
68
722
(3037756) Immunofixation for Serum or Plasma
107
903
1.19
0.98
1.5
1.7
—
—
—
0
0
(4024509)
35
257
1.36
0.98
1.5
1.4
—
—
—
0
0
(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid
0
30
0.00
0.97
0.0
1.1
—
6.2
—
0
6
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
347
3174
1.10
0.97
1.6
1.5
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
36
1.95
0.97
2.3
1.4
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
59
470
1.26
0.95
1.6
1.4
mmol/l
6.6
6.3
0.30
53
426
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
51
1.77
0.94
1.3
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
46
355
1.30
0.94
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
46
355
1.30
0.94
1.1
1.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
272
2462
1.11
0.94
1.5
1.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
19
125
1.52
0.93
2.2
1.7
ug/l
18.3
86.6
0.55
19
111
(21494890) Protein electrophoresis panel - 24 hour Urine
57
453
1.26
0.93
2.1
2.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
17
109
1.56
0.93
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
153
1746
0.87
0.93
10.2
4.4
mmol/l
24.7
24.6
0.08
144
1618
(44806420)
8
145
0.55
0.92
2.3
2.3
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
21
142
1.48
0.92
2.1
1.6
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
25
350
0.71
0.92
1.4
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
79
653
1.21
0.92
1.1
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
272
2993
0.90
0.91
4.3
4.4
mmol/l
1.2
1.2
0.13
249
2643
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
24
168
1.43
0.89
1.2
1.2
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
30
219
1.37
0.89
1.0
1.1
u/ml
2.8
4.0
0.35
13
86
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
26
185
1.41
0.89
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
33
245
1.35
0.88
1.5
1.5
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
8
42
1.91
0.88
1.6
1.7
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
62
502
1.24
0.88
1.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
42
324
1.30
0.88
1.8
1.9
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
42
324
1.30
0.88
1.8
1.9
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
42
324
1.30
0.88
1.8
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
18
119
1.51
0.88
1.2
1.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
85
712
1.20
0.87
1.2
1.3
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
6
30
2.00
0.87
1.0
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
42
325
1.30
0.86
1.6
2.4
e9/l
1.1
1.1
0.08
26
194
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
162
1830
0.88
0.86
1.8
1.9
ug/l
3.7
2.3
0.30
142
1630
(1616796) Gas panel - Central venous blood
113
973
1.17
0.85
4.1
4.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
239
2163
1.11
0.85
3.1
3.4
e9/l
4.2
4.3
0.35
174
1622
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
16
104
1.54
0.84
4.4
2.6
ug/l
1.9
1.1
0.60
16
97
(3021788) Differential panel - Synovial fluid
76
633
1.20
0.84
1.4
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
166
1867
0.88
0.83
3.3
3.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
44
345
1.28
0.82
1.2
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
8
46
1.74
0.82
1.4
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
28
376
0.74
0.82
1.2
1.2
mmol/l
7.5
7.7
0.11
19
259
(3024980) IgG subclass 4 [Mass/volume] in Serum
62
508
1.22
0.81
1.4
1.5
g/l
0.8
0.9
0.76
46
393
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
172
1.40
0.80
1.0
1.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
79
664
1.19
0.80
2.4
2.4
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
17
114
1.49
0.79
1.1
1.3
%
60.5
64.7
0.24
17
95
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
153
1356
1.13
0.79
3.3
3.2
mg/l
34.4
44.4
1.47
129
1062
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
22
156
1.41
0.78
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
44
348
1.27
0.78
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
259
2829
0.91
0.77
7.6
4.0
kpa
5.1
5.1
0.15
242
2603
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
44
349
1.26
0.77
1.1
1.1
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
153
1359
1.13
0.77
3.3
3.2
mg/l
55.9
67.1
0.60
127
1066
(3036525) Urea [Moles/time] in 24 hour Urine
6
34
1.77
0.76
2.2
3.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
219
1990
1.11
0.74
1.5
1.4
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
24
2.08
0.74
1.2
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
175
1.37
0.74
1.0
1.1
—
—
—
0
0
(40758047) Lysozyme [Mass/volume] in Pleural fluid
9
54
1.67
0.74
1.8
1.2
mg/l
8.8
8.6
—
9
48
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
31
236
1.32
0.74
1.5
2.1
%
15.6
15.8
0.03
18
94
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
9
55
1.64
0.73
15.7
10.9
mmol/l
5.0
6.1
—
9
55
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
75
634
1.19
0.73
1.1
1.2
u/ml
2.9
7.6
—
10
56
(40768806) Pleura Pathology biopsy report
63
524
1.21
0.73
1.8
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
76
644
1.18
0.72
2.8
2.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
108
0.55
0.72
1.0
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
83
709
1.17
0.72
2.4
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
156
1395
1.12
0.71
1.8
1.7
u/l
35.0
37.8
1.06
135
1213
(3043410) Blood group antigens tested for on Red Blood Cells
17
117
1.45
0.71
1.5
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
81
692
1.17
0.71
1.1
1.5
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
26
1.92
0.70
1.0
1.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
582
1.19
0.70
1.6
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
83
712
1.17
0.69
2.4
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
51
418
1.22
0.69
1.3
1.3
u/ml
6.6
4.4
0.54
27
201
(3000764) Benzodiazepines [Presence] in Urine
82
703
1.17
0.69
2.4
2.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
175
1580
1.11
0.69
1.2
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
19
135
1.41
0.69
6.8
7.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
13
85
1.53
0.68
1.1
2.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
273
2954
0.92
0.68
4.2
4.2
%
0.1
0.1
0.58
84
927
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
79
676
1.17
0.68
1.1
1.2
u/ml
26.1
38.5
—
7
27
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
311
1.26
0.67
1.0
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
91
0.55
0.67
1.0
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
92
0.54
0.67
1.0
1.1
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
5
28
1.79
0.66
1.2
1.1
u/l
38.6
14.4
—
5
28
(3009343) pH of Capillary blood
258
2792
0.92
0.66
7.6
4.0
ph
7.4
7.4
1.46
44
349
(3028433) Virus identified in Specimen by Culture
16
111
1.44
0.65
1.1
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
12
78
1.54
0.65
1.3
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
12
78
1.54
0.65
1.6
1.6
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
148
1329
1.12
0.65
3.3
3.2
ratio
2.0
3.8
—
7
101
(3000034) Microalbumin [Mass/volume] in Urine
30
382
0.78
0.64
3.0
3.2
mg/l
60.4
73.6
0.11
24
301
(3041806) Other cells [#/volume] in Blood by Manual count
5
29
1.72
0.64
1.2
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
290
3116
0.93
0.63
4.1
4.1
%
0.7
0.9
0.89
92
990
(3027135) IgG subclass 1 [Mass/volume] in Serum
39
315
1.24
0.62
1.2
1.3
g/l
7.3
6.4
0.82
27
220
(3024139) IgG subclass 3 [Mass/volume] in Serum
39
315
1.24
0.62
1.2
1.3
g/l
0.6
0.4
0.52
27
221
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
37
297
1.25
0.62
1.1
1.1
u/ml
1.8
2.9
1.01
14
123
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
250
2697
0.92
0.60
7.7
3.9
mmol/l
1.5
1.6
0.17
199
1957
(3028192) IgG subclass 2 [Mass/volume] in Serum
39
316
1.24
0.60
1.2
1.3
g/l
3.1
3.0
0.17
26
222
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
132
1184
1.12
0.60
1.8
1.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
137
0.66
0.60
2.2
2.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
137
0.66
0.60
2.3
2.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
402
4259
0.94
0.60
4.6
4.7
%
32.5
32.0
0.45
287
2918
(3025159) Blasts/100 leukocytes in Blood
258
2776
0.92
0.59
4.3
4.1
%
0.4
0.2
0.19
71
782
(1001926) Buprenorphine [Presence] in Urine by Screen method
64
547
1.17
0.58
2.7
2.4
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
7
113
0.62
0.58
1.3
1.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
74
641
1.16
0.58
1.1
1.2
u/ml
3.0
7.3
1.06
15
84
(3027944) Amphetamines [Presence] in Urine
80
698
1.15
0.57
1.5
2.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
134
1482
0.90
0.56
2.0
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
92
812
1.14
0.56
1.5
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
87
0.57
0.56
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
89
0.56
0.56
1.0
2.7
—
—
—
0
0
(4035726)
307
2878
1.07
0.55
1.4
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
77
672
1.15
0.55
1.3
1.4
e6/l
18.7
13.8
0.20
58
523
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
77
672
1.15
0.55
1.4
1.4
e6/l
1643.9
1005.0
0.17
63
549
(40768793) Breast Pathology biopsy report
12
171
0.70
0.54
1.3
1.3
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
38
1.58
0.54
1.7
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
60
515
1.17
0.54
3.6
4.8
umol/l
309.4
356.4
1.85
54
445
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
45
377
1.20
0.53
1.1
1.2
%
110.1
111.4
0.09
40
340
(3045424) Erythrocytes [Presence] in Urine
62
535
1.16
0.52
1.4
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
103
921
1.12
0.52
2.7
2.6
%
16.1
16.1
0.06
61
499
(3037692) Legionella sp identified in Specimen by Organism specific culture
19
143
1.33
0.52
1.5
1.5
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
9
63
1.43
0.52
1.2
1.2
umol/l
3.0
3.6
—
9
57
(3036071) Salmonella sp Ab [Titer] in Serum
6
97
0.62
0.52
1.2
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
99
0.61
0.51
1.7
2.7
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
6
40
1.50
0.51
2.5
1.3
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
40
1.50
0.51
1.0
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
36
296
1.22
0.51
1.0
1.1
u/ml
7.4
2.0
—
6
67
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
51
434
1.18
0.51
1.1
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
32
391
0.82
0.51
1.3
1.4
pmol/l
268.2
260.9
0.07
27
295
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
25
197
1.27
0.51
1.6
1.4
%
72.2
67.4
0.31
18
166
(3014133) Dog dander IgE Ab [Units/volume] in Serum
30
242
1.24
0.50
1.0
1.1
u/ml
1.7
2.4
0.39
12
94
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
104
933
1.12
0.50
1.4
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
92
1.41
0.50
6.3
7.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
15
202
0.74
0.50
2.9
2.3
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
41
1.46
0.50
3.0
2.3
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
6
41
1.46
0.50
1.2
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
41
1.46
0.50
1.8
2.5
mmol/l
2.8
2.8
—
6
35
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
56
482
1.16
0.49
1.5
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
29
234
1.24
0.49
1.5
2.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
25
198
1.26
0.49
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
25
198
1.26
0.49
1.0
1.0
—
—
—
0
0
(4146454)
39
465
0.84
0.49
2.5
2.7
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
20
257
0.78
0.49
2.0
1.6
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
70
614
1.14
0.49
1.2
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
178
0.73
0.48
1.0
1.6
—
—
—
0
0
(4306422)
46
392
1.18
0.46
1.3
1.2
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
17
129
1.32
0.45
2.1
1.8
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
119
0.67
0.45
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
18
138
1.31
0.45
9.3
7.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
18
138
1.31
0.45
1.6
3.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
27
219
1.23
0.45
3.1
2.8
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
24
192
1.25
0.44
7.7
5.5
u/ml
35.8
53.1
—
8
55
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
5
31
1.61
0.43
1.4
1.1
umol/24h
1.5
1.9
—
5
31
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
61
537
1.14
0.42
1.1
1.2
u/ml
15.9
2.5
—
10
34
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
6
91
0.66
0.42
1.5
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
32
1.56
0.42
1.6
1.5
—
—
—
0
0
(3019225) pH of Specimen
324
3407
0.95
0.42
4.6
4.7
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
19
149
1.28
0.41
1.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
1.6
—
0
10
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
6
(4062490)
37
314
1.18
0.41
1.2
1.3
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.0
—
0
7
(3040893) Potassium [Moles/volume] in Capillary blood
0
17
0.00
0.40
0.0
2.2
—
4.4
—
0
17
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.0
—
0
11
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
2.0
—
0
8
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
34
1.47
0.40
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
168
1.25
0.40
1.6
1.4
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
24
292
0.82
0.39
1.8
1.9
u/field
1.4
0.9
—
7
109
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
34
288
1.18
0.39
1.5
1.6
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
23
187
1.23
0.38
1.9
1.4
u/l
7.7
7.6
0.00
16
157
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
408
3912
1.05
0.38
1.9
1.8
%
1.6
1.6
0.10
345
3350
(3009214) Lutropin [Units/volume] in Serum or Plasma
93
846
1.10
0.38
1.3
1.4
u/l
6.0
7.1
0.82
77
691
(3008898) HLA-B27 [Presence]
80
722
1.11
0.38
1.2
1.1
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
144
1337
1.08
0.38
3.7
3.5
g/l
0.3
0.4
1.62
76
668
(3028026) IgM [Mass/volume] in Serum or Plasma
210
1977
1.07
0.38
1.6
1.9
g/l
1.2
1.4
0.23
187
1792
(3008536) Aspergillus sp Ab [Presence] in Serum
11
80
1.38
0.38
3.0
2.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1060
10845
0.97
0.38
3.0
3.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
67
1.34
0.38
1.3
1.2
—
—
—
0
0
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
15
192
0.78
0.38
2.0
1.3
u/l
90.1
95.8
0.12
15
158
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
85
771
1.10
0.37
1.2
1.3
mg/l
600.9
534.2
0.43
80
721
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
301
0.83
0.37
1.8
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
68
1.32
0.37
2.6
3.3
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
37
1.35
0.37
3.0
2.6
u/field
0.0
0.2
—
5
37
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
21
257
0.82
0.37
2.0
1.6
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
64
714
0.89
0.36
4.5
3.4
%
1.0
1.5
1.12
49
549
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
71
1.27
0.36
1.1
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
223
2110
1.06
0.35
3.1
2.7
—
—
—
0
0
(3004451) EKG impression Narrative
18
223
0.81
0.35
1.6
1.3
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
21
171
1.23
0.35
1.7
1.4
%
1.9
2.0
0.01
15
149
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
54
479
1.13
0.35
1.2
1.3
miu/ml
141.2
199.7
0.93
17
160
(40768795) Lymph node Pathology biopsy report
26
309
0.84
0.35
1.2
1.2
—
—
—
0
0
(3012501) Base excess in Blood by calculation
104
958
1.09
0.34
3.8
4.8
mmol/l
2.5
2.5
0.03
70
631
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
45
395
1.14
0.34
2.4
3.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
27
227
1.19
0.34
1.0
1.1
—
—
—
0
0
(44813793)
12
156
0.77
0.34
1.1
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
57
509
1.12
0.34
3.2
2.4
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
11
82
1.34
0.34
1.0
1.1
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
43
377
1.14
0.34
1.0
1.1
u/ml
1.0
1.8
0.73
15
158
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
35
302
1.16
0.33
1.4
1.3
—
—
—
0
0
(4211845)
19
154
1.23
0.33
1.6
3.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
18
221
0.81
0.33
1.6
2.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
14
109
1.29
0.33
1.6
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
14
109
1.29
0.33
1.9
2.8
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
89
0.67
0.33
1.3
1.9
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
78
853
0.91
0.32
1.3
1.2
titre
81.3
155.1
—
8
82
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
16
198
0.81
0.32
1.9
3.0
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
50
446
1.12
0.31
1.1
1.2
u/ml
25.5
35.2
—
7
30
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
31
267
1.16
0.31
1.0
1.0
ng/l
267.3
304.6
0.43
20
181
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
28
239
1.17
0.31
4.1
3.5
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
22
184
1.20
0.30
6.9
6.4
u/ml
4495.0
247.9
—
7
45
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
31
268
1.16
0.30
1.0
1.0
ng/l
35.4
41.9
0.44
19
176
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
31
268
1.16
0.30
1.0
1.0
ng/l
590.5
699.2
0.58
19
176
(3013512) EKG study
1026
10461
0.97
0.30
4.5
4.3
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
40
353
1.13
0.30
1.1
1.2
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
263
2518
1.05
0.29
2.4
2.7
g/l
10.7
10.7
0.01
232
2302
(3000285) Sodium [Moles/volume] in Blood
7
56
1.25
0.29
1.0
1.1
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
7
56
1.25
0.29
1.4
1.5
%
47.4
73.1
—
7
43
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
34
297
1.15
0.29
1.1
1.2
%
100.6
95.6
0.51
29
278
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
70
640
1.10
0.29
1.6
1.4
—
—
—
0
0
(4133840)
12
94
1.28
0.28
1.2
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
62
1.29
0.28
1.4
1.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
242
1.16
0.28
1.2
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
116
1087
1.07
0.27
10.2
3.6
kpa
8.0
8.0
0.00
109
1000
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
8
66
1.21
0.26
1.5
2.0
mg/l
6.4
8.0
—
8
53
(3000012) Reticulocyte production index
20
236
0.85
0.26
2.2
1.5
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
67
1.19
0.26
1.0
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
66
606
1.09
0.26
1.5
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
206
1.17
0.26
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
24
206
1.17
0.26
1.6
1.6
u/l
4.9
6.7
—
10
102
(3042010) Triglyceride [Moles/volume] in Pleural fluid
5
71
0.70
0.26
1.2
1.2
mmol/l
0.9
0.7
—
5
50
(3045683) HLA typing for celiac disease panel - Blood or Tissue
15
123
1.22
0.25
1.1
1.0
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
15
181
0.83
0.25
2.0
1.3
u/l
30.7
24.3
0.20
15
149
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
21
179
1.17
0.25
1.0
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
17
202
0.84
0.24
2.7
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
17
202
0.84
0.24
2.7
2.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
17
202
0.84
0.24
2.7
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
59
541
1.09
0.24
1.5
1.6
—
—
—
0
0
(3010421) pH of Blood
116
1094
1.06
0.24
3.7
4.7
ph
7.4
7.4
0.09
103
937
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
10
78
1.28
0.24
1.7
1.7
%
176.2
202.2
—
10
73
(40768441) Liver Pathology biopsy report
21
244
0.86
0.24
1.2
1.3
—
—
—
0
0
(4268621)
31
274
1.13
0.24
2.4
2.4
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
6
85
0.71
0.24
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
34
303
1.12
0.23
1.4
1.4
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
36
323
1.12
0.22
1.1
1.1
u/ml
0.1
1.1
1.93
12
139
(4281824)
14
167
0.84
0.21
1.1
1.2
—
—
—
0
0
(3006969) Lambda light chains [Mass/volume] in Urine
0
10
0.00
0.21
0.0
1.0
—
0.0
—
0
5
(3012989) Citrate [Moles/time] in 24 hour Urine
0
10
0.00
0.21
0.0
1.3
—
2.2
—
0
10
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
10
0.00
0.21
0.0
1.0
—
0.5
—
0
10
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.7
—
1.8
—
0
10
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
12
0.00
0.21
0.0
1.0
—
803.3
—
0
12
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
57
527
1.08
0.21
1.1
1.0
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
57
527
1.08
0.21
3.0
2.8
u/ml
4.5
347.4
2.81
57
512
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
15
126
1.19
0.21
1.0
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
10
80
1.25
0.20
1.5
1.8
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
10
123
0.81
0.20
1.0
1.2
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
49
451
1.09
0.20
1.3
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
112
0.80
0.20
1.1
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
20
229
0.87
0.20
2.9
2.3
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
185
1784
1.04
0.18
4.1
5.2
%
1.7
1.7
0.59
173
1660
(3048879) Bone marrow aspiration report
11
132
0.83
0.18
1.4
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
16
185
0.86
0.18
1.1
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
58
1.21
0.18
1.4
1.4
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
46
425
1.08
0.18
1.3
1.2
u/ml
1.9
2.4
0.63
21
146
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
70
658
1.06
0.18
1.8
1.8
ug/l
20.5
22.2
0.22
70
643
(21494755) Public health laboratory ask at order entry panel
227
2200
1.03
0.17
1.4
1.4
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
22
247
0.89
0.17
1.3
1.2
—
—
—
0
0
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
35
382
0.92
0.17
1.3
1.2
nmol/l
1.1
1.5
1.52
28
335
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
13
152
0.85
0.17
3.2
2.7
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
13
152
0.85
0.17
3.2
2.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
13
152
0.85
0.17
3.2
2.7
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
148
1.15
0.16
1.1
1.1
u/l
0.9
1.1
—
10
73
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
120
0.83
0.16
1.3
1.9
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
120
0.83
0.16
1.2
1.6
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
8
68
1.18
0.16
1.8
1.7
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
8
69
1.16
0.16
1.1
1.1
umol/l
18.0
16.0
—
8
63
(3023511) Choriogonadotropin [Units/volume] in Urine
14
120
1.17
0.16
1.3
1.3
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
36
331
1.09
0.16
1.0
1.1
u/ml
4.2
6.1
0.26
15
160
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
43
399
1.08
0.15
1.1
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
8
73
1.10
0.15
1.0
1.5
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
79
0.76
0.15
1.0
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
9
78
1.15
0.15
1.2
2.0
—
—
—
0
0
(1002224) Polysomnography panel
113
1177
0.96
0.15
1.1
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
35
323
1.08
0.14
1.9
1.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
87
0.80
0.14
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
100
959
1.04
0.14
1.7
1.7
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
16
141
1.14
0.13
2.6
1.7
e6/l
552.8
1001.7
0.82
11
102
(40761539) Cells [Type] in Urine sediment by Light microscopy
12
103
1.17
0.13
1.3
1.3
—
—
—
0
0
(4027681)
13
149
0.87
0.13
1.5
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
181
1760
1.03
0.13
4.2
5.3
%
0.9
0.9
0.70
169
1638
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
65
683
0.95
0.13
1.1
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
16
142
1.13
0.12
1.4
1.1
iu/ml
16.3
11.0
—
6
32
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
116
0.86
0.12
1.0
1.1
miu/ml
1159.8
1544.7
—
10
116
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
182
1.10
0.11
1.3
1.5
u/ml
4.9
2.5
0.27
12
95
(3051387) C reactive protein [Mass/volume] in Capillary blood
78
810
0.96
0.10
3.2
3.5
mg/l
28.7
32.9
0.50
55
529
(3023383) Lactate [Moles/volume] in Pleural fluid
16
177
0.90
0.10
1.1
1.3
mmol/l
3.1
3.6
0.30
16
161
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
96
1.15
0.10
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
183
1.09
0.10
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
20
183
1.09
0.10
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
183
1.09
0.10
1.0
1.1
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
5
45
1.11
0.09
1.2
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
5
45
1.11
0.09
1.2
1.3
—
—
—
0
0
(4198724)
10
114
0.88
0.09
1.7
3.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
47
1.06
0.09
1.0
1.2
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
31
291
1.07
0.09
1.2
1.2
nmol/l
367.5
331.7
0.48
26
224
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
48
1.04
0.09
2.4
2.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
48
1.04
0.09
2.4
2.3
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
11
124
0.89
0.09
1.0
1.1
g/l
—
0.1
—
0
8
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
11
97
1.13
0.09
1.7
1.6
%
150.7
178.1
0.53
11
90
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
30
282
1.06
0.08
1.4
1.2
titre
68.0
145.3
—
5
45
(3050129) First trimester maternal screen panel - Serum or Plasma
18
165
1.09
0.08
1.4
1.4
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
60
577
1.04
0.08
4.4
4.0
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
58
1.03
0.08
1.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
106
1032
1.03
0.08
1.3
1.3
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.0
1.3
ug/l
12.1
3.0
—
5
53
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
60
578
1.04
0.08
1.2
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
18
195
0.92
0.08
1.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
18
195
0.92
0.08
1.1
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
116
1188
0.98
0.08
3.8
3.1
mmol/l
24.6
24.6
0.00
106
1019
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
7
68
1.03
0.07
1.3
1.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
12
133
0.90
0.07
1.4
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
73
0.82
0.07
1.3
1.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
6
75
0.80
0.07
1.5
1.4
—
—
—
0
0
(4094501)
98
955
1.03
0.07
1.1
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
108
1.11
0.07
1.2
1.3
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
8
78
1.03
0.07
1.4
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
83
0.84
0.07
1.0
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
9
85
1.06
0.07
1.1
1.1
—
0.3
—
0
15
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
9
85
1.06
0.07
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
8
92
0.87
0.06
1.8
4.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
44
423
1.04
0.06
1.2
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
45
433
1.04
0.06
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
748
7528
0.99
0.06
1.7
1.8
pmol/l
28430180.4
30530449.5
0.03
605
6207
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
48
463
1.04
0.06
1.5
1.6
%
63.7
65.2
0.11
33
304
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
27
256
1.05
0.06
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
335
0.95
0.06
1.8
1.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
70
681
1.03
0.06
1.2
1.3
mmol/l
3.6
4.0
4.68
64
630
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
30
286
1.05
0.06
1.1
1.0
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
88
861
1.02
0.05
3.1
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
103
1050
0.98
0.05
3.4
3.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
46
445
1.03
0.05
5.1
4.1
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
22
208
1.06
0.05
2.7
11.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
100
1.10
0.05
1.0
1.0
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
110
0.91
0.05
1.2
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
19
179
1.06
0.04
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
19
179
1.06
0.04
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
19
179
1.06
0.04
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
70
716
0.98
0.04
1.2
1.3
u/l
97.1
37.4
0.55
64
628
(3028707) Methadone [Presence] in Urine by Screen method
34
328
1.04
0.04
3.9
3.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
24
251
0.96
0.04
1.2
1.2
—
29.9
—
0
11
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
34
351
0.97
0.03
1.3
1.5
%
25.2
24.1
0.08
27
226
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
169
0.95
0.03
1.2
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
18
171
1.05
0.03
3.4
5.1
mg/l
48.9
71.5
1.40
13
125
(3040151) Glucose [Moles/volume] in Capillary blood
52
509
1.02
0.03
6.5
21.4
mmol/l
7.5
7.6
0.02
42
421
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
122
1.07
0.02
1.8
1.5
—
—
—
0
0
(3019977) pH of Arterial blood
26
269
0.97
0.02
2.8
2.6
ph
7.4
7.4
0.09
15
101
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
13
138
0.94
0.02
1.7
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
13
138
0.94
0.02
1.7
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
13
138
0.94
0.02
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
13
138
0.94
0.02
1.7
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
18
188
0.96
0.02
1.4
1.6
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
18
188
0.96
0.02
1.4
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
42
429
0.98
0.02
2.6
2.2
mg/l
56.6
25.8
—
7
114
(3044927) Protein electrophoresis panel - Urine
44
431
1.02
0.02
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
44
431
1.02
0.02
4.8
3.5
%
60.9
58.0
0.36
30
280
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
25
258
0.97
0.02
1.2
1.2
mmol/l
12.8
11.9
—
8
93
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
25
258
0.97
0.02
1.4
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
59
581
1.02
0.02
1.1
1.1
iu/ml
85.1
341.8
0.44
11
117
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
133
1.05
0.01
1.1
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
153
1.05
0.01
1.7
1.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
163
1.04
0.01
1.8
1.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
89
898
0.99
0.01
2.2
2.6
umol/l
31.9
35.0
0.75
68
752
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
31
304
1.02
0.00
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
17
167
1.02
0.00
1.2
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
14
135
1.04
0.00
1.4
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
17
166
1.02
0.00
1.1
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
30
295
1.02
0.00
1.6
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
238
1.01
0.00
1.4
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
36
356
1.01
0.00
1.9
1.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
57
570
1.00
0.00
1.6
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
205
2053
1.00
0.00
3.5
3.7
mmol/l
25.3
25.0
0.49
196
1991
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
35
345
1.01
0.00
1.5
1.2
u/l
65.2
68.5
0.09
22
222
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
125
0.96
0.00
2.1
1.5
e6/l
5240.3
6283.4
—
7
72
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
10
103
0.97
0.00
1.0
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
103
0.97
0.00
1.5
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
19
188
1.01
0.00
2.6
2.4
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
19
191
0.99
0.00
1.6
1.7
u/field
3.2
3.2
0.01
13
141
(3016244) Insulin [Units/volume] in Serum or Plasma
12
117
1.03
0.00
2.7
3.1
mu/l
14.6
28.8
1.06
12
109
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
117
1.03
0.00
1.5
1.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
29
295
0.98
0.00
1.0
1.2
u/ml
3.8
34.3
—
5
12
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
31
306
1.01
0.00
2.5
2.3
u/l
14768.8
4222.6
—
6
100
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
12
120
1.00
0.00
1.3
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
24
243
0.99
0.00
1.4
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
118
1.02
0.00
1.8
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
118
1.02
0.00
1.8
1.4
—
—
—
0
0
(3044336) Cobalt [Moles/volume] in Urine
0
8
0.00
0.00
0.0
3.4
—
34.8
—
0
8
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
5
56
0.89
0.00
1.2
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
52
0.96
0.00
2.4
2.8
—
—
—
0
0
(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
0.2
—
0
9
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
6
61
0.98
0.00
2.0
2.6
—
71.6
—
0
11
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
39.2
—
0
6
(3021691) Plasmodium malariae Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
80
1.00
0.00
1.9
1.6
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
9
98
0.92
0.00
1.7
2.5
mmol/l
7.0
8.7
—
9
56
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
8
87
0.92
0.00
1.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
6
60
1.00
0.00
2.2
1.7
ng/l
132.2
173.9
—
6
60
(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
97
0.93
0.00
1.3
1.5
ug/l
10.3
9.9
—
9
97
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
49
1.02
0.00
1.0
1.2
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
52
0.96
0.00
4.8
5.7
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
72
0.97
0.00
1.3
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
52
0.96
0.00
1.2
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
8
80
1.00
0.00
1.0
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
90
1.00
0.00
1.7
1.6
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint HERING_BILATERAL and mortality.

Females

Parameter HR [95% CI] p-value
HERING_BILATERAL 1.146 [1.01, 1.3] 0.038
Birth year 0.993 [0.98, 1.0] 0.095

During the follow-up period (1.1.1998 — 31.12.2019), 657 out of 3063 females with HERING_BILATERAL died.

Males

Parameter HR [95% CI] p-value
HERING_BILATERAL 0.986 [0.91, 1.07] 0.741
Birth year 0.988 [0.98, 1.0] 0.009

During the follow-up period (1.1.1998 — 31.12.2019), 5117 out of 25068 males with HERING_BILATERAL died.

Mortality risk

Mortality risk for people of age

years, who have HERING_BILATERAL.

N-year risk Females Males
1 0.08% 0.224%
5 0.647% 1.255%
10 1.526% 3.107%
15 2.9% 5.815%
20 5.48% 9.394%

Relationships between endpoints

Index endpoint: HERING_BILATERAL – Inguinal hernia, bilateral

GWS hits: 7

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data